Related references
Note: Only part of the references are listed.Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+Oropharyngeal Squamous Cell Carcinoma
Yue Cao et al.
CLINICAL CANCER RESEARCH (2022)
Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary
Hidenori Tanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2022)
Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer
Lars Sivars et al.
GYNECOLOGIC ONCOLOGY (2022)
Circulating tumorHPV DNAcomplementsPET-CTin guiding management after radiotherapy inHPV-related squamous cell carcinoma of the head and neck
Hidenori Tanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC
Vincent K. Lam et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients
Karin Wallander et al.
PLOS ONE (2021)
Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer
Emmanuelle Jeannot et al.
CLINICAL CANCER RESEARCH (2021)
Characterisation of dysplastic liver nodules using low-pass DNA sequencing and detection of chromosome arm-level abnormalities in blood-derived cell-free DNA
Waleed Fateen et al.
JOURNAL OF PATHOLOGY (2021)
Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study
Jeffrey J. Szymanski et al.
PLOS MEDICINE (2021)
HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer
L. Cabel et al.
ESMO OPEN (2021)
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study
Alfredo Rivas-Delgado et al.
CLINICAL CANCER RESEARCH (2021)
Detection of cell-free circulating BRAFV600E by droplet digital polymerase chain reaction in patients with and without melanoma under dermatological surveillance
N. Calbet-Llopart et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers
David Veyer et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
Bhishamjit S. Chera et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis
Yasunori Uesato et al.
PLOS ONE (2020)
Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics
Ariana Rostami et al.
CELL REPORTS (2020)
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cell-free tumour DNA testing for early detection of cancer - a potential future tool
G. Barbany et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
J. Hamfjord et al.
ANNALS OF ONCOLOGY (2019)
Life and death of circulating cell-free DNA
Anatoli Kustanovich et al.
CANCER BIOLOGY & THERAPY (2019)
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Bhishamjit S. Chera et al.
CLINICAL CANCER RESEARCH (2019)
Liquid biopsy of HPV DNA in cervical cancer
Tak Hong Cheung et al.
JOURNAL OF CLINICAL VIROLOGY (2019)
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
Dominic G. Rothwell et al.
NATURE MEDICINE (2019)
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
Peter Ulz et al.
NATURE COMMUNICATIONS (2019)
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
J. Zugazagoitia et al.
ANNALS OF ONCOLOGY (2019)
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial
Alice Bernard-Tessier et al.
CLINICAL CANCER RESEARCH (2019)
Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer
Hiroki Osumi et al.
CANCER MEDICINE (2019)
The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature
Janine Aucamp et al.
BIOLOGICAL REVIEWS (2018)
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
Oliver A. Zill et al.
CLINICAL CANCER RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
David M. Kurtz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease
Joshua Moss et al.
NATURE COMMUNICATIONS (2018)
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma
Luc Cabel et al.
CLINICAL CANCER RESEARCH (2018)
Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA
Katrin Carow et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer
K. C. Allen Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia
Clementina Elvezia Cocuzza et al.
PLOS ONE (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring
Zhigang Kang et al.
CLINICAL CANCER RESEARCH (2017)
Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients
Anne Winther-Larsen et al.
BRITISH JOURNAL OF CANCER (2017)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma
Emmanuelle Jeannot et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2016)
Circulating Human Papillomavirus DNA as a Marker for Disease Extent and Recurrence Among Patients With Oropharyngeal Cancer
Kristina R. Dahlstrom et al.
CANCER (2015)
Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy
Peter G. Rose et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology
Louise T. Thomsen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A cut-off value of 2 cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer
Lars-Christian Horn et al.
GYNECOLOGIC ONCOLOGY (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Saliva and Plasma Quantitative Polymerase Chain Reaction-Based Detection and Surveillance of Human Papillomavirus-Related Head and Neck Cancer
Sun M. Ahn et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)
Quantitation of Human Papillomavirus DNA in Plasma of Oropharyngeal Carcinoma Patients
Hongbin Cao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Human Papillomavirus Mutational Insertion: Specific Marker of Circulating Tumor DNA in Cervical Cancer Patients
Maura Campitelli et al.
PLOS ONE (2012)
HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix
Koen D. Quint et al.
GYNECOLOGIC ONCOLOGY (2010)
Human Papillomavirus DNA in Plasma of Patients with HPV16 DNA-positive Uterine Cervical Cancer
Takako Shimada et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins
Mako Narisawa-Saito et al.
CANCER SCIENCE (2007)
Detection and typing of minimal human papillomavirus DNA in plasma
Yu-Chi Wei et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2007)
Detection and quantitation of human papillomavirus type 16, 18 and 52 DNA in the peripheral blood of cervical cancer patients
CM Ho et al.
GYNECOLOGIC ONCOLOGY (2005)
Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer
P Kay et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer
HJ Yang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2004)
HPV DNA in plasma of patients with cervical carcinoma
N Sathish et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis
RH Young et al.
HISTOPATHOLOGY (2002)
Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study
F Landoni et al.
GYNECOLOGIC ONCOLOGY (2001)
Share Paper
